Cannabidiol and Marihuana Research Expansion Act
Latest action · Mar 28, 2022 Held at the desk.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 4, 2021
- Passed SenateMar 24, 2022
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Cannabidiol and Marihuana Research Expansion Act
This bill establishes a new, separate registration process to facilitate research on marijuana.
Specifically, the bill directs the Drug Enforcement Administration (DEA) to follow specified procedures to register (1) practitioners to conduct marijuana research, and (2) manufacturers to supply marijuana for the research.
The bill allows certain registered entities (including institutions of higher education, practitioners, and manufacturers) to manufacture, distribute, dispense, or possess marijuana or cannabidiol (CBD) for the purposes of medical research. Additionally, the bill directs the DEA to register manufacturers and distributors of CBD or marijuana for the purpose of commercial production of an approved drug that contains marijuana or its derivative.
Finally, the bill includes various other provisions, including provisions that
- require the DEA to assess whether there is an adequate and uninterrupted supply of marijuana for research purposes;
- prohibit the Department of Health and Human Services (HHS) from reinstating the interdisciplinary review process for marijuana research;
- allow physicians to discuss the potential harms and benefits of marijuana and its derivatives (including CBD) with patients; and
- require HHS, in coordination with the National Institutes of Health and relevant federal agencies, to report on the therapeutic potential of marijuana for various conditions such as epilepsy, as well as the impact on adolescent brains and on the ability to operate a motor vehicle.
Cosponsors 10
Members who signed on, in the order they did. Signatures ran from Feb 4, 2021 to Mar 3, 2021; 9 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MN | Amy Klobuchar | Original | Feb 4, 2021 |
| D-HI | Brian Schatz | Original | Feb 4, 2021 |
| R-IA | Chuck Grassley | Original | Feb 4, 2021 |
| D-MT | Jon Tester | Original | Feb 4, 2021 |
| R-IA | Joni Ernst | Original | Feb 4, 2021 |
| R-AK | Lisa Murkowski | Original | Feb 4, 2021 |
| D-IL | Richard J. Durbin | Original | Feb 4, 2021 |
| R-NC | Thom Tillis | Original | Feb 4, 2021 |
| D-VA | Tim Kaine | Original | Feb 4, 2021 |
| R-ND | Kevin Cramer | Mar 3, 2021 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Judiciary Committee | Referred Feb 5, 2021Discharged Mar 24, 2022 |
Actions 8
Everything that happened, newest first.
- Mar 28, 2022Message on Senate action sent to the House.
- Mar 28, 2022Received in the House.
- Mar 28, 2022Held at the desk.
- Mar 24, 2022Senate Committee on the Judiciary discharged by Unanimous Consent.
- Mar 24, 2022Measure laid before Senate by unanimous consent. (consideration: CR S1784)
In the Congressional Record 3
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S1784Amendments S1781 | Charles E. Schumer D-NY, Dianne Feinstein D-CA (amendment) | Mar 24, 2022 |
| Senate | Debate and remarks S9176 | Chuck Grassley R-IA | Dec 15, 2021 |
| Senate | Debate and remarks S477 | Dianne Feinstein D-CA | Feb 4, 2021 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Printed hearings 2
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| — | COMMERCE, JUSTICE, SCIENCE, AND RELATED AGENCIES APPROPRIATIONS FOR FISCAL YEAR 202254 pages | Appropriations Committee | Jun 9, 2021 |
| S. Hrg. 117-650 | COMMERCE, JUSTICE, SCIENCE, AND RELATED AGENCIES APPROPRIATIONS FOR FISCAL YEAR 2022418 pages | Appropriations Committee | Apr 13, 2021–Jun 23, 2021 |
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R44782 | The Evolution of Marijuana as a Controlled Substance and the Federal-State Policy Gap | Report | Apr 7, 2022 |
Amendments 1
Amendments offered to this bill.
| Amendment | Description | Offered by | Status |
|---|---|---|---|
| SA 5015 | In the nature of a substitute. | Dianne Feinstein D-CA | Amendment SA 5015 agreed to in Senate by Unanimous Consent. |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 8454 | Medical Marijuana and Cannabidiol Research Expansion Act | Related bill | Dec 2, 2022 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to expand research on the cannabidiol and marihuana.
- Short Title(s) as Introduced
- Cannabidiol and Marihuana Research Expansion Act
- Short Title(s) as Passed Senate
- Cannabidiol and Marihuana Research Expansion Act
Subjects
Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.
- Congressional oversight
- Crime and Law Enforcement
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Health personnel
- Health programs administration and funding
- Licensing and registrations
- Medical research
- Public-private cooperation
- Research administration and funding
- Trade restrictions
Text 2
Each version as it was printed, newest first.
- Mar 24, 2022Engrossed in Senate
- Feb 4, 2021Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
